Beyond the Standard: Individualized Approaches to Dual Antiplatelet Therapy Gain Attention
Dirk Sibbing, Professor, Cardiologist and Angiologist at Privatklinik Lauterbacher Mühle and LMU Munich, shared an insightful post on LinkedIn:
”When it comes to dual antiplatelet treatment we are still using a non-individualized approach in our everyday clinical practice for patients after PCI.
However, evidence is accumulating that sex, age, BMI and many more variables may constitute relevant treatment effect modifiers for drugs like clopidogrel, prasugrel or ticagrelor.
See the latest data on DAPT and sex in the European Heart Journal and my Editorial that puts the findings into perspective.”
Read the full article here.
Article: Dual antiplatelet therapy modulation strategies beyond standard of care: a promising path towards individualized antiplatelet treatment
Author: Dirk Sibbing
Stay updated on all science in the field of hematology with Hemostasis Today.
-
Aug 10, 2025, 02:59What's Hot in Clots – August 2025: Explore AF, PFO, STROKE, Antithrombotics and Cancer in One
-
Aug 8, 2025, 18:06Catch Up on Anticoagulation Forum Newsletter: Explore The Upcoming
-
Aug 8, 2025, 15:28Claudio Laudani: New Insights on P2Y12 Monotherapy in Antiplatelet Therapy
-
Aug 8, 2025, 11:59Wolfgang Miesbach on Frailty in Hemophilia: New Data Shows 3x Higher Risk
-
Aug 8, 2025, 06:26Francisco López Romero-Salazar Shares A Closer Look at ROTEM and Thrombin Generation Assays
-
Aug 10, 2025, 06:33CRH: Hereditary Combined Deficiency of the Vitamin K-Dependent Coagulation Factors
-
Aug 10, 2025, 06:01Karl Desch Shares Insights On a Recent Study on GWAS by Thibord et al
-
Aug 10, 2025, 04:39Sara García Barcenilla: High-Quality Care for People with Hemophilia and Congenital Bleeding Disorders
-
Aug 10, 2025, 01:12PROTECmo Study: Thrombocytopenia in VenoVenous ECMO Linked to High Bleeding Risk
-
Aug 9, 2025, 17:30Ayesha Butt: Role of Neutrophil Extracellular Traps in APS-Related Thrombosis
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot
-
Aug 8, 2025, 18:33Hemophilia Alliance during Tennessee Hemophilia and Bleeding Disorders Foundation Annual Meeting 2025
-
Aug 7, 2025, 14:49JAMA+AI Conversations: David Rhew's Journey from Clinical Practice to Technology Leadership
-
Aug 6, 2025, 16:47My Clot Story: Birth Control and A Life-threatening Pulmonary Embolism
-
Aug 5, 2025, 17:59Heghine Khachatryan: Honored to Be Part of The WFH Regional Workshop 2025